Bio-Path Holdings, Inc.
BPTH- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001133818
No open-market purchases or sales by Bio-Path Holdings, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding Bio-Path Holdings, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 17 | 17 | 0 |
| Shares | 450.2K | 392.6K | −57.6K (−12.8%) |
| Value | $1.70M | $1.51M | −$189.0K (−11.1%) |
New holders (4)
Institutions that held Bio-Path Holdings, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Virtu Financial LLC | 10,012 | $38.0K | 0.00% |
| Tower Research Capital LLC (TRC) | 1,222 | $5.00K | 0.00% |
| Money Concepts Capital Corp | 300 | $1.00K | 0.00% |
| Royal Bank of Canada | 20 | $0 | 0.00% |
Sold out (4)
Institutions that held Bio-Path Holdings, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Bailard, Inc. | 33,521 | $126.0K |
| Dimensional Fund Advisors LP | 15,375 | $58.0K |
| AdvisorNet Financial, Inc | 40 | $0 |
| Aquire Wealth Advisors, LLC | 3 | $0 |